Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Mindray Receives CE Mark for HIV and HBV Test Kits

Mindray Receives CE Mark for HIV and HBV Test Kits

Oct 24, 2017
|
staff reporter

NEW YORK (360Dx) – Shenzhen, China-based Mindray said today that it has received CE marking for its HIV and HBV test kits for HBsAg, Anti-HBs, Anti-HBc, HBeAg, and Anti-HBe.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand

    Premium

  2. BARDA Awards $684K to Luminex for Enhanced COVID-19 Multiplex Antibody Test

  3. BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

  4. FDA Grants Emergency Use Authorizations for Quadrant Biosciences, KimForest Coronavirus Tests

  5. FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.